Myrexis, Inc. (MYRX) は上場企業です 金融 セクターの Shell Companies 業界で事業展開. 本社所在地は New York City, NY, アメリカ. 現CEOは Jonathan Couchman.
MYRX を有する IPO日 2009-06-12, 1 名の正社員, に上場 Other OTC, 時価総額 $20.69K.
Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.
